BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30742237)

  • 41. Who benefits from red blood cell salvage?--Utility and value of intraoperative autologous transfusion.
    Frank SM
    Transfusion; 2011 Oct; 51(10):2058-60. PubMed ID: 21985041
    [No Abstract]   [Full Text] [Related]  

  • 42. Tranexamic acid: more evidence for its use in joint replacement surgery.
    Raveendran R; Wong J
    Transfusion; 2014 Jan; 54(1):2-3. PubMed ID: 24405302
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases.
    Attaran S; McIlroy D; Fabri BM; Pullan MD
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):824-6. PubMed ID: 21297148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Oremus K; Sostaric S; Trkulja V; Haspl M
    Transfusion; 2014 Jan; 54(1):31-41. PubMed ID: 23614539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraoperative blood salvage in revision total hip arthroplasty: who benefits most?
    Greenky M; Shaner J; Rasouli MR; Han SB; Parvizi J; Hozack WJ
    J Arthroplasty; 2014 Jun; 29(6):1298-300. PubMed ID: 24412146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrolyte and acid/base changes in dogs undergoing autologous blood transfusion via a cell salvage device.
    Lamb JL; Thieman Mankin KM; Levine GJ; Thompson J
    Can Vet J; 2015 Sep; 56(9):947-52. PubMed ID: 26345136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irrationality of Allogeneic Red Blood Cell Transfusion in Intraoperative Cell Salvage Patients: a Retrospective Analysis.
    Ma M; Yu XR; Wang Y; Huang YG; Lu SF; Tian Y; Bai B
    Chin Med Sci J; 2018 Jun; 33(2):77-83. PubMed ID: 29976276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective analysis of the efficacy of perioperative use of the cell salvage and autologous blood recovery system during laparoscopic myomectomy.
    Kumakiri J; Kikuchi I; Kitade M; Matsuoka S; Kono A; Takeda S
    Arch Gynecol Obstet; 2012 Apr; 285(4):1073-7. PubMed ID: 22012250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autologous blood transfusion following red blood cell salvage for the management of blood loss in 3 dogs with hemoperitoneum.
    Hirst C; Adamantos S
    J Vet Emerg Crit Care (San Antonio); 2012 Jun; 22(3):355-60. PubMed ID: 22702441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device.
    Boyle G; Kuffel A; Parmar K; Gibson K; Smith M; Grehan A; Hunt BJ; Chambers DJ
    Perfusion; 2019 Jan; 34(1):76-83. PubMed ID: 30067140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of cell saver use in living-donor liver transplant.
    Kırnap M; Tezcaner T; Ayvazoğlu Soy HE; Akdur A; Yıldırım S; Torgay A; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():315-7. PubMed ID: 25894181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices.
    Baumann C; Lamesic G; Weiss M; Cushing MM; Haas T
    Paediatr Anaesth; 2015 Mar; 25(3):258-64. PubMed ID: 25267461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Should intraoperative cell-salvaged blood be used in patients with suspected or known malignancy?
    Trudeau JD; Waters T; Chipperfield K
    Can J Anaesth; 2012 Nov; 59(11):1058-70. PubMed ID: 22996966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Processing of small volumes in blood salvage devices.
    Seyfried T; Breu A; Gruber M; Reipert J; Hansen E
    Transfusion; 2014 Oct; 54(10 Pt 2):2775-81. PubMed ID: 24953124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perioperative Blood Management in Posterior Instrumented Fusion for Adolescent Idiopathic Scoliosis: Original Study and Short Review of the Literature.
    Katranitsa L; Gkantsinikoudis N; Kapetanakis S; Charitoudis G; Christodoulou A; Givissis P
    Folia Med (Plovdiv); 2018 Jun; 60(2):200-207. PubMed ID: 30355823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood transfusions in radical prostatectomy: a contemporary population-based analysis.
    Schmitges J; Sun M; Abdollah F; Trinh QD; Jeldres C; Budäus L; Bianchi M; Hansen J; Schlomm T; Perrotte P; Graefen M; Karakiewicz PI
    Urology; 2012 Feb; 79(2):332-8. PubMed ID: 22310749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vancomycin added to the wash solution of the cell-saver. Effect on bacterial contamination.
    Perez-Ferrer A; Gredilla-Díaz E; de Vicente-Sánchez J; Navarro-Suay R; Gilsanz-Rodríguez F
    Rev Esp Anestesiol Reanim; 2017 Apr; 64(4):185-191. PubMed ID: 28094033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive factors for the use of autologous cell saver transfusion in lumbar spinal surgery.
    Owens RK; Crawford CH; Djurasovic M; Canan CE; Burke LO; Bratcher KR; McCarthy KJ; Carreon LY
    Spine (Phila Pa 1976); 2013 Feb; 38(4):E217-22. PubMed ID: 23197016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophil extracellular traps were released during intraoperative blood salvage in posterior lumbar surgery.
    Zheng L; Tian M; Zhang Y; Dong P; Yang H
    Transfus Apher Sci; 2018 Apr; 57(2):259-264. PubMed ID: 29602707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy.
    Myrga JM; Ayyash OM; Bandari J; Fam MM; Macleod LC; Jacobs BL; Davies BJ
    Urology; 2020 Jan; 135():106-110. PubMed ID: 31626857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.